First Trust NYSE Arca Biotechnology Index Fund
218 hedge funds and large institutions have $625M invested in First Trust NYSE Arca Biotechnology Index Fund in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 72 reducing their positions, and 26 closing their positions.
627% more call options, than puts
Call options by funds: $2.2M | Put options by funds: $303K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
6% more capital invested
Capital invested by funds: $588M → $625M (+$36.5M)
5.89% more ownership
Funds ownership: 46.12% → 52.01% (+5.9%)
3% less funds holding
Funds holding: 224 → 218 (-6)
17% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 72
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOS
Silver Oak Securities
Jackson,
Tennessee
|
+$60.2M |
| 2 |
JAWM
J. Arnold Wealth Management
Youngstown,
Ohio
|
+$9.59M |
| 3 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$8.96M |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$8.17M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMF
Sterling Manor Financial
Saratoga Springs,
New York
|
-$4.78M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.59M |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$3.37M |
| 4 |
TFA
TPG Financial Advisors
Portland,
Oregon
|
-$2.05M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.47M |
FBT Hedge Fund Activity: Q3 2022 in Review
218 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2022, worth a combined $625M — up 6.2% from $588M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of FBT and 20 opened new positions — a net loss of 6 holders — while 72 trimmed existing stakes and 60 added.
The largest buyer was Silver Oak Securities, opening a new position worth an estimated $60.2M. The largest seller was Sterling Manor Financial, exiting entirely with an estimated $4.78M sold.
- 218 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2022, down from 224 in Q2 2022.
- Funds reported $625M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2022, up 6.2% quarter-over-quarter.
- 20 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2022 and 26 closed out, a net change of -6 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2022 was Silver Oak Securities, an estimated $60.2M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2022 was Sterling Manor Financial, an estimated $4.78M sold.
Based on aggregated 13F filings for Q3 2022.